Trial Details

Authorised
Basic Information
Clinical ID c2695
Identifier EUCTR2018-004967-30-GB
Trial Title IBD Reference and Biosimilar adalimumab CroSS over Study - iBaSS
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Crohn disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: Imraldi Product Name: Imraldi Pharmaceutical Form: Injection INN or Proposed INN: adalimumab CAS Number: 331731-18-1 Concentration unit: mg milligram(s) Concentration type: equal Trade Name: Humira Product Name: Humira Pharmaceutical Form: Injection INN or Proposed INN: adalimumab CAS Number: 331731-18-1 Concentration unit: mg milligram(s) Concentration type: equal
Participant Information
Sponsor University Hospital Southampton NHS Foundation Trust
City -
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -